Thomas NE - Search Results

1

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, Alldredge VD, Parrish E, Hanna SC, Berkowitz P, Rubenstein DS, Miller CR, Bear JE, Ollila DW, Sharpless NE, Conway K, Thomas NE. Carson CC, et al. Among authors: thomas ne. Clin Cancer Res. 2015 May 1;21(9):2167-76. doi: 10.1158/1078-0432.CCR-14-1826. Clin Cancer Res. 2015. PMID: 25934889 Free PMC article.

2

Tandem BRAF mutations in primary invasive melanomas.

Thomas NE, Alexander A, Edmiston SN, Parrish E, Millikan RC, Berwick M, Groben P, Ollila DW, Mattingly D, Conway K. Thomas NE, et al. J Invest Dermatol. 2004 May;122(5):1245-50. doi: 10.1111/j.0022-202X.2004.22523.x. J Invest Dermatol. 2004. PMID: 15140228 Free article.

3

Invasive superficial spreading melanomas arising from clinically normal skin.

Thomas NE, Groben P. Thomas NE, et al. J Am Acad Dermatol. 2004 Sep;51(3):466-70. doi: 10.1016/j.jaad.2004.04.027. J Am Acad Dermatol. 2004. PMID: 15337995

4

Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).

Stitzenberg KB, Groben PA, Stern SL, Thomas NE, Hensing TA, Sansbury LB, Ollila DW. Stitzenberg KB, et al. Among authors: thomas ne. Ann Surg Oncol. 2004 Oct;11(10):900-6. doi: 10.1245/ASO.2004.10.002. Epub 2004 Sep 20. Ann Surg Oncol. 2004. PMID: 15383424

5

Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma.

Stitzenberg KB, Thomas NE, Beskow LM, Ollila DW. Stitzenberg KB, et al. Among authors: thomas ne. J Surg Oncol. 2006 Feb 1;93(2):100-7; discussion 107-8. doi: 10.1002/jso.20403. J Surg Oncol. 2006. PMID: 16425313

6

Influence of provider and practice characteristics on melanoma care.

Stitzenberg KB, Thomas NE, Ollila DW. Stitzenberg KB, et al. Among authors: thomas ne. Am J Surg. 2007 Feb;193(2):206-12. doi: 10.1016/j.amjsurg.2006.06.038. Am J Surg. 2007. PMID: 17236848

7

RNA expression analysis of formalin-fixed paraffin-embedded tumors.

Penland SK, Keku TO, Torrice C, He X, Krishnamurthy J, Hoadley KA, Woosley JT, Thomas NE, Perou CM, Sandler RS, Sharpless NE. Penland SK, et al. Among authors: thomas ne. Lab Invest. 2007 Apr;87(4):383-91. doi: 10.1038/labinvest.3700529. Epub 2007 Feb 12. Lab Invest. 2007. PMID: 17297435 Free article.

8

Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.

Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, Torrice C, Hao H, Penland S, Arbiser J, Scott G, Zhou T, Bar-Eli M, Bear JE, Der CJ, Kaufmann WK, Rimm DL, Sharpless NE. Shields JM, et al. Among authors: thomas ne. Cancer Res. 2007 Feb 15;67(4):1502-12. doi: 10.1158/0008-5472.CAN-06-3311. Cancer Res. 2007. PMID: 17308088

9

Eruptive post-chemotherapy in situ melanomas and dysplastic nevi.

Reutter JC, Long EM, Morrell DS, Thomas NE, Groben PA. Reutter JC, et al. Among authors: thomas ne. Pediatr Dermatol. 2007 Mar-Apr;24(2):135-7. doi: 10.1111/j.1525-1470.2007.00359.x. Pediatr Dermatol. 2007. PMID: 17461808

10

Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K. Thomas NE, et al. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):991-7. doi: 10.1158/1055-9965.EPI-06-1038. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17507627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters